| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 1.81e-09 | 26 | 41 | 5 | GO:0005248 | |
| GeneOntologyMolecularFunction | sodium channel activity | 6.86e-08 | 52 | 41 | 5 | GO:0005272 | |
| GeneOntologyMolecularFunction | sodium ion binding | 2.88e-06 | 14 | 41 | 3 | GO:0031402 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 5.36e-06 | 17 | 41 | 3 | GO:0099508 | |
| GeneOntologyMolecularFunction | chromatin binding | 1.50e-05 | 739 | 41 | 9 | GO:0003682 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 2.02e-05 | 26 | 41 | 3 | GO:0031420 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 2.54e-05 | 171 | 41 | 5 | GO:0015081 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 3.14e-05 | 30 | 41 | 3 | GO:0070577 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 3.47e-05 | 31 | 41 | 3 | GO:0140033 | |
| GeneOntologyMolecularFunction | H3K27me3 modified histone binding | 4.10e-05 | 5 | 41 | 2 | GO:0061628 | |
| GeneOntologyMolecularFunction | histone modifying activity | 1.02e-04 | 229 | 41 | 5 | GO:0140993 | |
| GeneOntologyMolecularFunction | RNA polymerase I general transcription initiation factor activity | 1.47e-04 | 9 | 41 | 2 | GO:0001181 | |
| GeneOntologyMolecularFunction | histone binding | 2.01e-04 | 265 | 41 | 5 | GO:0042393 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 3.25e-04 | 459 | 41 | 6 | GO:0005216 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 3.36e-04 | 66 | 41 | 3 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 3.36e-04 | 66 | 41 | 3 | GO:0001098 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 6.55e-04 | 343 | 41 | 5 | GO:0005261 | |
| GeneOntologyMolecularFunction | channel activity | 6.60e-04 | 525 | 41 | 6 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 6.67e-04 | 526 | 41 | 6 | GO:0022803 | |
| GeneOntologyMolecularFunction | methylated histone binding | 7.31e-04 | 86 | 41 | 3 | GO:0035064 | |
| GeneOntologyMolecularFunction | transcription factor binding | 7.74e-04 | 753 | 41 | 7 | GO:0008134 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 7.81e-04 | 88 | 41 | 3 | GO:0140034 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 8.26e-04 | 206 | 41 | 4 | GO:0140030 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 1.13e-03 | 582 | 41 | 6 | GO:0140297 | |
| GeneOntologyMolecularFunction | RNA polymerase II core promoter sequence-specific DNA binding | 1.20e-03 | 25 | 41 | 2 | GO:0000979 | |
| GeneOntologyMolecularFunction | RNA polymerase II general transcription initiation factor binding | 1.40e-03 | 27 | 41 | 2 | GO:0001091 | |
| GeneOntologyMolecularFunction | actin monomer binding | 1.61e-03 | 29 | 41 | 2 | GO:0003785 | |
| GeneOntologyMolecularFunction | TBP-class protein binding | 2.09e-03 | 33 | 41 | 2 | GO:0017025 | |
| GeneOntologyMolecularFunction | transcription regulator inhibitor activity | 2.48e-03 | 36 | 41 | 2 | GO:0140416 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 2.52e-03 | 465 | 41 | 5 | GO:0046873 | |
| GeneOntologyMolecularFunction | ubiquitin conjugating enzyme activity | 2.62e-03 | 37 | 41 | 2 | GO:0061631 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein conjugating enzyme activity | 3.52e-03 | 43 | 41 | 2 | GO:0061650 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 4.24e-03 | 758 | 41 | 6 | GO:0015318 | |
| GeneOntologyMolecularFunction | gated channel activity | 4.78e-03 | 334 | 41 | 4 | GO:0022836 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 4.92e-03 | 51 | 41 | 2 | GO:0004402 | |
| GeneOntologyMolecularFunction | RNA polymerase II general transcription initiation factor activity | 5.11e-03 | 52 | 41 | 2 | GO:0016251 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 5.28e-03 | 793 | 41 | 6 | GO:0015075 | |
| GeneOntologyMolecularFunction | core promoter sequence-specific DNA binding | 5.70e-03 | 55 | 41 | 2 | GO:0001046 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 5.70e-03 | 55 | 41 | 2 | GO:0061733 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 6.16e-03 | 182 | 41 | 3 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 6.35e-03 | 184 | 41 | 3 | GO:0022832 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 6.63e-03 | 187 | 41 | 3 | GO:0016922 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 6.75e-03 | 60 | 41 | 2 | GO:0034212 | |
| GeneOntologyMolecularFunction | general transcription initiation factor binding | 7.65e-03 | 64 | 41 | 2 | GO:0140296 | |
| GeneOntologyMolecularFunction | general transcription initiation factor activity | 8.60e-03 | 68 | 41 | 2 | GO:0140223 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 8.85e-03 | 627 | 41 | 5 | GO:0022890 | |
| GeneOntologyMolecularFunction | p53 binding | 1.09e-02 | 77 | 41 | 2 | GO:0002039 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 1.12e-02 | 664 | 41 | 5 | GO:0008324 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 1.12e-02 | 78 | 41 | 2 | GO:0008080 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | 1.17e-02 | 938 | 41 | 6 | GO:0016772 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 1.26e-02 | 83 | 41 | 2 | GO:1990841 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 5.84e-09 | 36 | 38 | 5 | GO:0086010 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 8.52e-08 | 121 | 38 | 6 | GO:0051899 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 9.68e-08 | 62 | 38 | 5 | GO:0086002 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 1.05e-07 | 63 | 38 | 5 | GO:0019228 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 5.35e-07 | 87 | 38 | 5 | GO:0086001 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 5.73e-07 | 167 | 38 | 6 | GO:0060048 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 7.46e-07 | 93 | 38 | 5 | GO:0086003 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 1.88e-06 | 112 | 38 | 5 | GO:0019226 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 2.64e-06 | 217 | 38 | 6 | GO:0006941 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 3.49e-06 | 127 | 38 | 5 | GO:0070252 | |
| GeneOntologyBiologicalProcess | chromatin organization | 3.55e-06 | 896 | 38 | 10 | GO:0006325 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 6.07e-06 | 741 | 38 | 9 | GO:0006338 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 8.67e-06 | 153 | 38 | 5 | GO:0030048 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 9.29e-06 | 999 | 38 | 10 | GO:0071824 | |
| GeneOntologyBiologicalProcess | heart contraction | 1.62e-05 | 298 | 38 | 6 | GO:0060047 | |
| GeneOntologyBiologicalProcess | heart process | 1.99e-05 | 309 | 38 | 6 | GO:0003015 | |
| GeneOntologyBiologicalProcess | behavioral response to pain | 2.76e-05 | 32 | 38 | 3 | GO:0048266 | |
| GeneOntologyBiologicalProcess | action potential | 3.23e-05 | 201 | 38 | 5 | GO:0001508 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 3.81e-05 | 208 | 38 | 5 | GO:0035725 | |
| GeneOntologyBiologicalProcess | negative regulation of heterochromatin formation | 4.93e-05 | 6 | 38 | 2 | GO:0031452 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | 6.29e-05 | 559 | 38 | 7 | GO:0042391 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception of pain | 6.77e-05 | 43 | 38 | 3 | GO:0062149 | |
| GeneOntologyBiologicalProcess | negative regulation of chromatin organization | 6.90e-05 | 7 | 38 | 2 | GO:1905268 | |
| GeneOntologyBiologicalProcess | muscle contraction | 8.37e-05 | 400 | 38 | 6 | GO:0006936 | |
| GeneOntologyBiologicalProcess | response to pain | 1.13e-04 | 51 | 38 | 3 | GO:0048265 | |
| GeneOntologyBiologicalProcess | response to insecticide | 1.18e-04 | 9 | 38 | 2 | GO:0017085 | |
| GeneOntologyBiologicalProcess | facultative heterochromatin formation | 1.42e-04 | 55 | 38 | 3 | GO:0140718 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 1.42e-04 | 275 | 38 | 5 | GO:0006814 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus involved in sensory perception | 1.58e-04 | 57 | 38 | 3 | GO:0050974 | |
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | 3.31e-04 | 330 | 38 | 5 | GO:0040029 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus | 3.55e-04 | 75 | 38 | 3 | GO:0050982 | |
| GeneOntologyBiologicalProcess | transcription initiation at RNA polymerase II promoter | 3.72e-04 | 186 | 38 | 4 | GO:0006367 | |
| GeneOntologyBiologicalProcess | muscle system process | 4.54e-04 | 547 | 38 | 6 | GO:0003012 | |
| GeneOntologyBiologicalProcess | negative regulation of gene expression, epigenetic | 5.17e-04 | 203 | 38 | 4 | GO:0045814 | |
| GeneOntologyBiologicalProcess | nucleolus organization | 6.79e-04 | 21 | 38 | 2 | GO:0007000 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription initiation | 8.39e-04 | 231 | 38 | 4 | GO:0006352 | |
| GeneOntologyBiologicalProcess | regulation of heterochromatin formation | 8.89e-04 | 24 | 38 | 2 | GO:0031445 | |
| GeneOntologyBiologicalProcess | sensory perception of pain | 9.50e-04 | 105 | 38 | 3 | GO:0019233 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus involved in sensory perception of pain | 1.04e-03 | 26 | 38 | 2 | GO:0050966 | |
| GeneOntologyBiologicalProcess | detection of temperature stimulus involved in sensory perception of pain | 1.04e-03 | 26 | 38 | 2 | GO:0050965 | |
| GeneOntologyBiologicalProcess | response to mechanical stimulus | 1.08e-03 | 247 | 38 | 4 | GO:0009612 | |
| GeneOntologyBiologicalProcess | circadian rhythm | 1.09e-03 | 248 | 38 | 4 | GO:0007623 | |
| GeneOntologyBiologicalProcess | blood circulation | 1.10e-03 | 648 | 38 | 6 | GO:0008015 | |
| GeneOntologyBiologicalProcess | actin filament-based process | 1.23e-03 | 912 | 38 | 7 | GO:0030029 | |
| GeneOntologyBiologicalProcess | detection of temperature stimulus involved in sensory perception | 1.39e-03 | 30 | 38 | 2 | GO:0050961 | |
| GeneOntologyBiologicalProcess | regulation of presynaptic membrane potential | 1.58e-03 | 32 | 38 | 2 | GO:0099505 | |
| GeneOntologyBiologicalProcess | multicellular organismal response to stress | 1.61e-03 | 126 | 38 | 3 | GO:0033555 | |
| GeneOntologyBiologicalProcess | detection of temperature stimulus | 1.68e-03 | 33 | 38 | 2 | GO:0016048 | |
| GeneOntologyBiologicalProcess | circulatory system process | 2.06e-03 | 733 | 38 | 6 | GO:0003013 | |
| GeneOntologyBiologicalProcess | sensory perception of temperature stimulus | 2.23e-03 | 38 | 38 | 2 | GO:0050951 | |
| GeneOntologyBiologicalProcess | regulation of chromatin organization | 2.47e-03 | 40 | 38 | 2 | GO:1902275 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.20e-10 | 17 | 40 | 5 | GO:0001518 | |
| GeneOntologyCellularComponent | sodium channel complex | 2.27e-09 | 29 | 40 | 5 | GO:0034706 | |
| GeneOntologyCellularComponent | C-fiber | 2.14e-05 | 4 | 40 | 2 | GO:0044299 | |
| GeneOntologyCellularComponent | MLL1 complex | 3.10e-05 | 32 | 40 | 3 | GO:0071339 | |
| GeneOntologyCellularComponent | MLL1/2 complex | 3.40e-05 | 33 | 40 | 3 | GO:0044665 | |
| GeneOntologyCellularComponent | nuclear DNA-directed RNA polymerase complex | 6.37e-05 | 113 | 40 | 4 | GO:0055029 | |
| GeneOntologyCellularComponent | DNA-directed RNA polymerase complex | 7.05e-05 | 116 | 40 | 4 | GO:0000428 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 7.67e-05 | 378 | 40 | 6 | GO:0034702 | |
| GeneOntologyCellularComponent | RNA polymerase complex | 7.79e-05 | 119 | 40 | 4 | GO:0030880 | |
| GeneOntologyCellularComponent | cation channel complex | 8.21e-05 | 235 | 40 | 5 | GO:0034703 | |
| GeneOntologyCellularComponent | intercalated disc | 2.98e-04 | 68 | 40 | 3 | GO:0014704 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 3.98e-04 | 75 | 40 | 3 | GO:0035097 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 4.44e-04 | 523 | 40 | 6 | GO:1902495 | |
| GeneOntologyCellularComponent | transporter complex | 5.79e-04 | 550 | 40 | 6 | GO:1990351 | |
| GeneOntologyCellularComponent | RNA polymerase II, holoenzyme | 6.58e-04 | 89 | 40 | 3 | GO:0016591 | |
| GeneOntologyCellularComponent | main axon | 6.58e-04 | 89 | 40 | 3 | GO:0044304 | |
| GeneOntologyCellularComponent | node of Ranvier | 6.64e-04 | 20 | 40 | 2 | GO:0033268 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 7.71e-04 | 94 | 40 | 3 | GO:0044291 | |
| GeneOntologyCellularComponent | methyltransferase complex | 1.15e-03 | 108 | 40 | 3 | GO:0034708 | |
| GeneOntologyCellularComponent | pronucleus | 1.31e-03 | 28 | 40 | 2 | GO:0045120 | |
| GeneOntologyCellularComponent | axon | 1.36e-03 | 891 | 40 | 7 | GO:0030424 | |
| GeneOntologyCellularComponent | axon initial segment | 1.40e-03 | 29 | 40 | 2 | GO:0043194 | |
| GeneOntologyCellularComponent | presynaptic membrane | 1.89e-03 | 277 | 40 | 4 | GO:0042734 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 3.55e-03 | 785 | 40 | 6 | GO:0098797 | |
| GeneOntologyCellularComponent | transcription factor TFIID complex | 3.65e-03 | 47 | 40 | 2 | GO:0005669 | |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 3.76e-03 | 335 | 40 | 4 | GO:0061695 | |
| GeneOntologyCellularComponent | synaptic membrane | 4.87e-03 | 583 | 40 | 5 | GO:0097060 | |
| GeneOntologyCellularComponent | chromatin | 6.20e-03 | 1480 | 40 | 8 | GO:0000785 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 8.04e-03 | 1228 | 40 | 7 | GO:0036477 | |
| GeneOntologyCellularComponent | transferase complex | 9.45e-03 | 963 | 40 | 6 | GO:1990234 | |
| GeneOntologyCellularComponent | lamellipodium | 9.63e-03 | 230 | 40 | 3 | GO:0030027 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | 9.87e-03 | 972 | 40 | 6 | GO:0140535 | |
| GeneOntologyCellularComponent | T-tubule | 1.00e-02 | 79 | 40 | 2 | GO:0030315 | |
| HumanPheno | Photosensitive myoclonic seizure | 1.71e-06 | 8 | 17 | 3 | HP:0001327 | |
| HumanPheno | Cyanotic episode | 1.71e-06 | 8 | 17 | 3 | HP:0200048 | |
| HumanPheno | Limited neck range of motion | 5.01e-06 | 11 | 17 | 3 | HP:0000466 | |
| HumanPheno | Epilepsia partialis continua | 6.67e-06 | 12 | 17 | 3 | HP:0012847 | |
| HumanPheno | Compulsive behaviors | 7.55e-06 | 158 | 17 | 6 | HP:0000722 | |
| HumanPheno | Restricted or repetitive behaviors or interests | 9.37e-06 | 368 | 17 | 8 | HP:0031432 | |
| HumanPheno | Perseverative thought | 1.12e-05 | 377 | 17 | 8 | HP:0030223 | |
| HumanPheno | Short attention span | 1.23e-05 | 517 | 17 | 9 | HP:0000736 | |
| HumanPheno | Autistic behavior | 1.32e-05 | 678 | 17 | 10 | HP:0000729 | |
| HumanPheno | Disordered formal thought process | 1.34e-05 | 386 | 17 | 8 | HP:0025769 | |
| HumanPheno | Photosensitive tonic-clonic seizure | 1.37e-05 | 15 | 17 | 3 | HP:0007207 | |
| HumanPheno | Facial tics | 1.37e-05 | 15 | 17 | 3 | HP:0011468 | |
| HumanPheno | Reduced attention regulation | 1.42e-05 | 526 | 17 | 9 | HP:5200044 | |
| HumanPheno | Dysgenesis of the hippocampus | 1.68e-05 | 16 | 17 | 3 | HP:0025101 | |
| HumanPheno | Complex febrile seizure | 1.68e-05 | 16 | 17 | 3 | HP:0011172 | |
| HumanPheno | Abnormal thought pattern | 1.88e-05 | 404 | 17 | 8 | HP:5200269 | |
| HumanPheno | Focal motor status epilepticus | 2.04e-05 | 17 | 17 | 3 | HP:0032663 | |
| HumanPheno | Bilateral tonic-clonic seizure with generalized onset | 2.08e-05 | 52 | 17 | 4 | HP:0025190 | |
| HumanPheno | Hyperactivity | 2.31e-05 | 558 | 17 | 9 | HP:0000752 | |
| HumanPheno | Visually-induced seizure | 2.44e-05 | 18 | 17 | 3 | HP:0020216 | |
| HumanPheno | Pes valgus | 2.80e-05 | 56 | 17 | 4 | HP:0008081 | |
| HumanPheno | Diagnostic behavioral phenotype | 3.17e-05 | 747 | 17 | 10 | HP:0025783 | |
| HumanPheno | Arachnoid cyst | 3.23e-05 | 58 | 17 | 4 | HP:0100702 | |
| HumanPheno | Abnormal arachnoid mater morphology | 3.45e-05 | 59 | 17 | 4 | HP:0100700 | |
| HumanPheno | Reflex seizure | 4.57e-05 | 22 | 17 | 3 | HP:0020207 | |
| HumanPheno | Generalized tonic seizure | 4.77e-05 | 64 | 17 | 4 | HP:0010818 | |
| HumanPheno | Tibial torsion | 5.25e-05 | 23 | 17 | 3 | HP:0100694 | |
| HumanPheno | Abnormal response to social norms | 6.32e-05 | 807 | 17 | 10 | HP:5200123 | |
| HumanPheno | Social disinhibition | 6.32e-05 | 807 | 17 | 10 | HP:5200029 | |
| HumanPheno | Disinhibition | 6.32e-05 | 807 | 17 | 10 | HP:0000734 | |
| HumanPheno | Inappropriate behavior | 6.32e-05 | 807 | 17 | 10 | HP:0000719 | |
| HumanPheno | Poor fine motor coordination | 6.43e-05 | 69 | 17 | 4 | HP:0007010 | |
| HumanPheno | Focal hemiclonic seizure | 6.79e-05 | 25 | 17 | 3 | HP:0006813 | |
| HumanPheno | Simple febrile seizure | 8.60e-05 | 27 | 17 | 3 | HP:0011171 | |
| HumanPheno | Limited knee extension | 8.60e-05 | 27 | 17 | 3 | HP:0003066 | |
| HumanPheno | Status epilepticus without prominent motor symptoms | 8.60e-05 | 27 | 17 | 3 | HP:0031475 | |
| HumanPheno | Impulsivity | 9.32e-05 | 149 | 17 | 5 | HP:0100710 | |
| HumanPheno | Focal aware seizure | 9.61e-05 | 28 | 17 | 3 | HP:0002349 | |
| HumanPheno | Allodynia | 1.04e-04 | 5 | 17 | 2 | HP:0012533 | |
| HumanPheno | Status epilepticus with prominent motor symptoms | 1.07e-04 | 29 | 17 | 3 | HP:0032658 | |
| HumanPheno | Aggressive behavior | 1.12e-04 | 516 | 17 | 8 | HP:0000718 | |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | 1.12e-04 | 516 | 17 | 8 | HP:0006919 | |
| HumanPheno | Progressive gait ataxia | 1.19e-04 | 30 | 17 | 3 | HP:0007240 | |
| HumanPheno | Progressive ataxia | 1.19e-04 | 30 | 17 | 3 | HP:0001329 | |
| HumanPheno | Clonic seizure | 1.21e-04 | 81 | 17 | 4 | HP:0020221 | |
| HumanPheno | Abnormally increased volition | 1.22e-04 | 869 | 17 | 10 | HP:5200263 | |
| HumanPheno | Prominent forehead | 1.31e-04 | 261 | 17 | 6 | HP:0011220 | |
| HumanPheno | Cogwheel rigidity | 1.44e-04 | 32 | 17 | 3 | HP:0002396 | |
| HumanPheno | Poor motor coordination | 1.46e-04 | 85 | 17 | 4 | HP:0002275 | |
| HumanPheno | Hypoplastic philtrum | 1.56e-04 | 6 | 17 | 2 | HP:0005326 | |
| HumanPheno | Obsessive-compulsive trait | 1.58e-04 | 33 | 17 | 3 | HP:0008770 | |
| HumanPheno | Generalized clonic seizure | 1.73e-04 | 34 | 17 | 3 | HP:0011169 | |
| HumanPheno | Abnormal social development | 1.79e-04 | 908 | 17 | 10 | HP:0025732 | |
| HumanPheno | Limitation of knee mobility | 1.89e-04 | 35 | 17 | 3 | HP:0010501 | |
| HumanPheno | Motor stereotypy | 1.93e-04 | 280 | 17 | 6 | HP:0000733 | |
| HumanPheno | Limitation of neck motion | 2.06e-04 | 36 | 17 | 3 | HP:0005986 | |
| HumanPheno | Disturbance of facial expression | 2.06e-04 | 36 | 17 | 3 | HP:0005324 | |
| HumanPheno | Abnormal neck physiology | 2.06e-04 | 36 | 17 | 3 | HP:0025669 | |
| HumanPheno | Attention deficit hyperactivity disorder | 2.08e-04 | 413 | 17 | 7 | HP:0007018 | |
| HumanPheno | Abnormal temper tantrums | 2.24e-04 | 37 | 17 | 3 | HP:0025160 | |
| HumanPheno | Focal clonic seizure | 3.27e-04 | 42 | 17 | 3 | HP:0002266 | |
| HumanPheno | Synophrys | 3.32e-04 | 195 | 17 | 5 | HP:0000664 | |
| HumanPheno | Oral-pharyngeal dysphagia | 4.02e-04 | 45 | 17 | 3 | HP:0200136 | |
| HumanPheno | Facial hypertrichosis | 4.28e-04 | 206 | 17 | 5 | HP:0002219 | |
| HumanPheno | Atypical absence seizure | 4.29e-04 | 46 | 17 | 3 | HP:0007270 | |
| HumanPheno | Abnormality of upper lip vermillion | 4.30e-04 | 464 | 17 | 7 | HP:0011339 | |
| HumanPheno | Abnormality of pain sensation | 4.37e-04 | 113 | 17 | 4 | HP:0010832 | |
| HumanPheno | Erythromelalgia | 4.64e-04 | 10 | 17 | 2 | HP:0032147 | |
| HumanPheno | Bradykinesia | 4.83e-04 | 116 | 17 | 4 | HP:0002067 | |
| HumanPheno | Abnormal hippocampus morphology | 4.87e-04 | 48 | 17 | 3 | HP:0025100 | |
| HumanPheno | Prominent digit pad | 4.87e-04 | 48 | 17 | 3 | HP:0011298 | |
| HumanPheno | Rigidity | 5.11e-04 | 214 | 17 | 5 | HP:0002063 | |
| HumanPheno | Abnormal morphology of the limbic system | 5.17e-04 | 49 | 17 | 3 | HP:0007343 | |
| HumanPheno | Epileptic encephalopathy | 5.33e-04 | 119 | 17 | 4 | HP:0200134 | |
| HumanPheno | Reduced impulse control | 5.37e-04 | 1032 | 17 | 10 | HP:5200045 | |
| HumanPheno | Thin upper lip vermilion | 5.48e-04 | 339 | 17 | 6 | HP:0000219 | |
| HumanPheno | Thin lips | 5.48e-04 | 339 | 17 | 6 | HP:0000213 | |
| HumanPheno | Maladaptive fear-related cognitions | 5.51e-04 | 483 | 17 | 7 | HP:5200230 | |
| HumanPheno | Anxiety | 5.51e-04 | 483 | 17 | 7 | HP:0000739 | |
| HumanPheno | Broad chin | 5.67e-04 | 11 | 17 | 2 | HP:0011822 | |
| HumanPheno | Focal-onset seizure | 6.12e-04 | 346 | 17 | 6 | HP:0007359 | |
| HumanPheno | Decreased/absent ankle reflexes | 6.53e-04 | 53 | 17 | 3 | HP:0200101 | |
| HumanPheno | Focal impaired awareness seizure | 6.62e-04 | 126 | 17 | 4 | HP:0002384 | |
| HumanPheno | Focal automatism seizure | 6.78e-04 | 12 | 17 | 2 | HP:0032898 | |
| HumanPheno | Medial flaring of the eyebrow | 6.84e-04 | 228 | 17 | 5 | HP:0010747 | |
| HumanPheno | Generalized cerebral atrophy/hypoplasia | 8.00e-04 | 13 | 17 | 2 | HP:0007058 | |
| HumanPheno | Pes planus | 8.15e-04 | 365 | 17 | 6 | HP:0001763 | |
| HumanPheno | Abnormal judgment | 8.26e-04 | 516 | 17 | 7 | HP:5200401 | |
| HumanPheno | Myoclonic absence seizure | 9.32e-04 | 14 | 17 | 2 | HP:0011150 | |
| HumanPheno | Parkinsonism | 9.33e-04 | 138 | 17 | 4 | HP:0001300 | |
| HumanPheno | Tonic seizure | 9.84e-04 | 140 | 17 | 4 | HP:0032792 | |
| HumanPheno | Dialeptic seizure | 1.06e-03 | 251 | 17 | 5 | HP:0011146 | |
| HumanPheno | Abnormal fear-induced behavior | 1.06e-03 | 538 | 17 | 7 | HP:0100852 | |
| HumanPheno | Aortopulmonary collateral arteries | 1.07e-03 | 15 | 17 | 2 | HP:0031834 | |
| HumanPheno | Infection-related seizure | 1.12e-03 | 145 | 17 | 4 | HP:0032892 | |
| HumanPheno | Seizure precipitated by febrile infection | 1.12e-03 | 145 | 17 | 4 | HP:0032894 | |
| HumanPheno | Febrile seizure (within the age range of 3 months to 6 years) | 1.12e-03 | 145 | 17 | 4 | HP:0002373 | |
| HumanPheno | Absence seizures with special features | 1.22e-03 | 16 | 17 | 2 | HP:0011148 | |
| HumanPheno | Multifocal epileptiform discharges | 1.24e-03 | 66 | 17 | 3 | HP:0010841 | |
| HumanPheno | Impairment in personality functioning | 1.25e-03 | 1141 | 17 | 10 | HP:0031466 | |
| MousePheno | abnormal nervous system electrophysiology | 1.17e-05 | 329 | 34 | 7 | MP:0002272 | |
| MousePheno | embryonic lethality prior to organogenesis | USP36 KMT2A DIDO1 CTNNA1 SRBD1 MAP1B CTCF ARHGEF7 CDCA5 CTR9 RAI1 POLR3G | 1.44e-05 | 1204 | 34 | 12 | MP:0013292 |
| MousePheno | embryonic lethality prior to tooth bud stage | USP36 KMT2A DIDO1 CTNNA1 SRBD1 MAP1B CTCF ARHGEF7 CDCA5 CTR9 RAI1 POLR3G | 5.79e-05 | 1383 | 34 | 12 | MP:0013293 |
| MousePheno | abnormal posture | 2.81e-04 | 243 | 34 | 5 | MP:0001504 | |
| MousePheno | abnormal action potential | 2.91e-04 | 133 | 34 | 4 | MP:0005402 | |
| MousePheno | decreased thermal nociceptive threshold | 3.00e-04 | 54 | 34 | 3 | MP:0003998 | |
| Domain | Na_channel_asu | 8.69e-12 | 10 | 40 | 5 | IPR001696 | |
| Domain | Na_trans_assoc | 8.69e-12 | 10 | 40 | 5 | IPR010526 | |
| Domain | Na_trans_assoc | 8.69e-12 | 10 | 40 | 5 | PF06512 | |
| Domain | Channel_four-helix_dom | 1.34e-07 | 57 | 40 | 5 | IPR027359 | |
| Domain | - | 1.34e-07 | 57 | 40 | 5 | 1.20.120.350 | |
| Domain | Na_trans_cytopl | 1.81e-07 | 6 | 40 | 3 | PF11933 | |
| Domain | Na_trans_cytopl | 1.81e-07 | 6 | 40 | 3 | IPR024583 | |
| Domain | Ion_trans_dom | 4.30e-06 | 114 | 40 | 5 | IPR005821 | |
| Domain | Ion_trans | 4.30e-06 | 114 | 40 | 5 | PF00520 | |
| Domain | TAF_II_230-bd | 4.47e-06 | 2 | 40 | 2 | IPR009067 | |
| Domain | DUF3591 | 4.47e-06 | 2 | 40 | 2 | PF12157 | |
| Domain | TFIID_sub1_DUF3591 | 4.47e-06 | 2 | 40 | 2 | IPR022591 | |
| Domain | - | 4.47e-06 | 2 | 40 | 2 | 1.10.1100.10 | |
| Domain | TBP-binding | 4.47e-06 | 2 | 40 | 2 | PF09247 | |
| Domain | TAF1_animal | 4.47e-06 | 2 | 40 | 2 | IPR011177 | |
| Domain | PHD | 3.86e-05 | 89 | 40 | 4 | SM00249 | |
| Domain | IQ_motif_EF-hand-BS | 4.04e-05 | 90 | 40 | 4 | IPR000048 | |
| Domain | Znf_PHD | 4.21e-05 | 91 | 40 | 4 | IPR001965 | |
| Domain | IQ | 4.59e-05 | 93 | 40 | 4 | PS50096 | |
| Domain | ZF_PHD_2 | 4.99e-05 | 95 | 40 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 5.20e-05 | 96 | 40 | 4 | PS01359 | |
| Domain | BROMODOMAIN_2 | 9.17e-05 | 41 | 40 | 3 | PS50014 | |
| Domain | BROMO | 9.86e-05 | 42 | 40 | 3 | SM00297 | |
| Domain | Bromodomain | 9.86e-05 | 42 | 40 | 3 | IPR001487 | |
| Domain | - | 9.86e-05 | 42 | 40 | 3 | 1.20.920.10 | |
| Domain | Znf_FYVE_PHD | 2.70e-04 | 147 | 40 | 4 | IPR011011 | |
| Domain | IQ | 4.70e-04 | 71 | 40 | 3 | PF00612 | |
| Domain | PHD | 5.52e-04 | 75 | 40 | 3 | PF00628 | |
| Domain | Znf_PHD-finger | 6.43e-04 | 79 | 40 | 3 | IPR019787 | |
| Domain | IQ | 6.92e-04 | 81 | 40 | 3 | SM00015 | |
| Domain | EPHD | 1.01e-03 | 22 | 40 | 2 | PS51805 | |
| Domain | Bromodomain_CS | 1.41e-03 | 26 | 40 | 2 | IPR018359 | |
| Domain | BROMODOMAIN_1 | 2.84e-03 | 37 | 40 | 2 | PS00633 | |
| Domain | Bromodomain | 2.99e-03 | 38 | 40 | 2 | PF00439 | |
| Domain | TPR_8 | 5.75e-03 | 53 | 40 | 2 | PF13181 | |
| Domain | Ig_I-set | 7.77e-03 | 190 | 40 | 3 | IPR013098 | |
| Domain | I-set | 7.77e-03 | 190 | 40 | 3 | PF07679 | |
| Domain | Zinc_finger_PHD-type_CS | 8.54e-03 | 65 | 40 | 2 | IPR019786 | |
| Domain | RhoGEF | 9.32e-03 | 68 | 40 | 2 | SM00325 | |
| Domain | DH_2 | 9.85e-03 | 70 | 40 | 2 | PS50010 | |
| Domain | RhoGEF | 9.85e-03 | 70 | 40 | 2 | PF00621 | |
| Domain | DH-domain | 1.01e-02 | 71 | 40 | 2 | IPR000219 | |
| Domain | - | 1.01e-02 | 71 | 40 | 2 | 1.20.900.10 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 2.86e-09 | 31 | 27 | 5 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 3.39e-09 | 32 | 27 | 5 | M27455 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 1.90e-06 | 203 | 27 | 6 | M5485 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 2.98e-06 | 121 | 27 | 5 | M872 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 4.24e-06 | 130 | 27 | 5 | M27454 | |
| Pathway | WP_DRAVET_SYNDROME | 1.99e-05 | 28 | 27 | 3 | M45519 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 5.57e-05 | 367 | 27 | 6 | M48346 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ESTABLISHMENT_OF_COHESION | 7.38e-05 | 7 | 27 | 2 | M47869 | |
| Pathway | WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME | 9.00e-05 | 46 | 27 | 3 | MM15949 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | SCN10A KMT2A SCN11A H1-8 CTNNA1 CTCF ARHGEF7 SCN1A SCN2A SCN3A | 1.89e-04 | 1432 | 27 | 10 | M509 |
| Pathway | WP_DRAVET_SYNDROME_SCN1AA1783V_POINT_MUTATION_MODEL | 3.56e-04 | 73 | 27 | 3 | MM16641 | |
| Pathway | KEGG_MEDICUS_REFERENCE_COHESIN_DISSOCIATION_IN_PROPHASE | 4.17e-04 | 16 | 27 | 2 | M47870 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS | 4.84e-04 | 81 | 27 | 3 | M865 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS | 5.20e-04 | 83 | 27 | 3 | MM15314 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 6.38e-04 | 575 | 27 | 6 | M29853 | |
| Pathway | PID_LIS1_PATHWAY | 1.29e-03 | 28 | 27 | 2 | M163 | |
| Pathway | PID_AURORA_A_PATHWAY | 1.59e-03 | 31 | 27 | 2 | M242 | |
| Pathway | WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME | 1.91e-03 | 34 | 27 | 2 | M42555 | |
| Pathway | KEGG_BASAL_TRANSCRIPTION_FACTORS | 2.02e-03 | 35 | 27 | 2 | M4864 | |
| Pubmed | 2.52e-13 | 9 | 42 | 5 | 16382098 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | USP36 PHF2 KMT2A DIDO1 CHD6 QSER1 SRBD1 CDC27 CTCF TAF1L CDCA5 CTR9 HNRNPAB RAI1 KNOP1 | 1.28e-11 | 1294 | 42 | 15 | 30804502 |
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 2.75e-11 | 6 | 42 | 4 | 23652591 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | USP36 PHF2 KMT2A DIDO1 TAF1 QSER1 MAP1B CTCF TAF1L CDCA5 HNRNPAB RAI1 KNOP1 | 5.61e-11 | 954 | 42 | 13 | 36373674 |
| Pubmed | 1.30e-09 | 13 | 42 | 4 | 15123669 | ||
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 12610651 | ||
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 23859570 | ||
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 14973256 | ||
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 18784617 | ||
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 17544618 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 2.20e-09 | 608 | 42 | 10 | 36089195 | |
| Pubmed | 6.54e-09 | 4 | 42 | 3 | 17537961 | ||
| Pubmed | 6.54e-09 | 4 | 42 | 3 | 35031483 | ||
| Pubmed | 6.54e-09 | 4 | 42 | 3 | 29578003 | ||
| Pubmed | 6.54e-09 | 4 | 42 | 3 | 35801810 | ||
| Pubmed | Use of recombinant inbred strains for studying genetic determinants of responses to alcohol. | 6.54e-09 | 4 | 42 | 3 | 8974318 | |
| Pubmed | 1.63e-08 | 5 | 42 | 3 | 1679748 | ||
| Pubmed | 1.63e-08 | 5 | 42 | 3 | 8812438 | ||
| Pubmed | 1.63e-08 | 5 | 42 | 3 | 24337656 | ||
| Pubmed | 3.27e-08 | 6 | 42 | 3 | 23711479 | ||
| Pubmed | Pain without nociceptors? Nav1.7-independent pain mechanisms. | 5.71e-08 | 7 | 42 | 3 | 24440715 | |
| Pubmed | 9.13e-08 | 8 | 42 | 3 | 25101983 | ||
| Pubmed | 1.37e-07 | 9 | 42 | 3 | 15746173 | ||
| Pubmed | 3.58e-07 | 12 | 42 | 3 | 8169823 | ||
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 3.58e-07 | 12 | 42 | 3 | 30175250 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 4.35e-07 | 394 | 42 | 7 | 27248496 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 5.68e-07 | 410 | 42 | 7 | 26949251 | |
| Pubmed | Confirmation of quantitative trait loci for alcohol preference in mice. | 7.38e-07 | 15 | 42 | 3 | 9726281 | |
| Pubmed | KMT2A SCN11A CHD6 SRBD1 ARMC3 MAP1B CDC27 CTR9 HNRNPAB RAI1 KNOP1 | 7.83e-07 | 1442 | 42 | 11 | 35575683 | |
| Pubmed | 9.07e-07 | 645 | 42 | 8 | 25281560 | ||
| Pubmed | 1.08e-06 | 281 | 42 | 6 | 24163370 | ||
| Pubmed | USP36 PHF2 KMT2A DIDO1 CHD6 SRBD1 CDC27 CTCF TAF1L CTR9 KNOP1 | 1.13e-06 | 1497 | 42 | 11 | 31527615 | |
| Pubmed | The contribution of de novo coding mutations to autism spectrum disorder. | 1.32e-06 | 18 | 42 | 3 | 25363768 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 1.41e-06 | 934 | 42 | 9 | 33916271 | |
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 28450535 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 38804708 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 29649454 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 34405474 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 20346423 | ||
| Pubmed | Heat-resistant action potentials require TTX-resistant sodium channels NaV1.8 and NaV1.9. | 1.42e-06 | 2 | 42 | 2 | 29970412 | |
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 26311622 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 19931571 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 10070062 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 18399542 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 24144460 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 22842574 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 34930944 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 16857712 | ||
| Pubmed | Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. | 1.42e-06 | 2 | 42 | 2 | 10827969 | |
| Pubmed | Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A. | 1.42e-06 | 2 | 42 | 2 | 15249644 | |
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 27690330 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 19694741 | ||
| Pubmed | Genomic structures of SCN2A and SCN3A - candidate genes for deafness at the DFNA16 locus. | 1.42e-06 | 2 | 42 | 2 | 11245985 | |
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 27571988 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 34403156 | ||
| Pubmed | The Nav1.9 channel is a key determinant of cold pain sensation and cold allodynia. | 1.42e-06 | 2 | 42 | 2 | 25959819 | |
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 31534133 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 21377452 | ||
| Pubmed | Differential expression of two sodium channel subtypes in human brain. | 1.42e-06 | 2 | 42 | 2 | 1317301 | |
| Pubmed | Correlations in timing of sodium channel expression, epilepsy, and sudden death in Dravet syndrome. | 1.42e-06 | 2 | 42 | 2 | 23965409 | |
| Pubmed | Duplication of the sodium channel gene cluster on 2q24 in children with early onset epilepsy. | 1.42e-06 | 2 | 42 | 2 | 23016767 | |
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 27153334 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 33096315 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 27245092 | ||
| Pubmed | Electrophysiological Differences between the Same Pore Region Mutation in SCN1A and SCN3A. | 1.42e-06 | 2 | 42 | 2 | 24990319 | |
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 31439038 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 30693367 | ||
| Pubmed | 2.21e-06 | 503 | 42 | 7 | 16964243 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 2.87e-06 | 1318 | 42 | 10 | 30463901 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 3.78e-06 | 349 | 42 | 6 | 25665578 | |
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 19284629 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 19270815 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 29655203 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 28784306 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 16052353 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 32185219 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 38999942 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 32005694 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 25155934 | ||
| Pubmed | TAFII55 binding to TAFII250 inhibits its acetyltransferase activity. | 4.27e-06 | 3 | 42 | 2 | 11592977 | |
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 33895391 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 30395542 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 17928448 | ||
| Pubmed | Yield of peripheral sodium channels gene screening in pure small fibre neuropathy. | 4.27e-06 | 3 | 42 | 2 | 30554136 | |
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 19699781 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 16822332 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 12217962 | ||
| Pubmed | TAF7: a possible transcription initiation check-point regulator. | 4.27e-06 | 3 | 42 | 2 | 16407123 | |
| Pubmed | Nerve injury induces robust allodynia and ectopic discharges in Nav1.3 null mutant mice. | 4.27e-06 | 3 | 42 | 2 | 17052333 | |
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 32845893 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 28518218 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 27816501 | ||
| Pubmed | 5.43e-06 | 210 | 42 | 5 | 16565220 | ||
| Pubmed | 5.46e-06 | 1103 | 42 | 9 | 34189442 | ||
| Pubmed | Targeted DNA Sequencing from Autism Spectrum Disorder Brains Implicates Multiple Genetic Mechanisms. | 8.53e-06 | 4 | 42 | 2 | 26637798 | |
| Pubmed | 8.53e-06 | 4 | 42 | 2 | 21156207 | ||
| Pubmed | 8.53e-06 | 4 | 42 | 2 | 9626495 | ||
| Pubmed | 8.53e-06 | 4 | 42 | 2 | 22260870 | ||
| Pubmed | 1.21e-05 | 653 | 42 | 7 | 22586326 | ||
| Pubmed | Pain-causing stinging nettle toxins target TMEM233 to modulate NaV1.7 function. | 1.42e-05 | 5 | 42 | 2 | 37117223 | |
| Interaction | H3C1 interactions | USP36 NUCKS1 KMT2A DIDO1 TAF1 SRBD1 CDC27 CTCF CDCA5 CTR9 HNRNPAB COBLL1 KNOP1 WDR46 | 1.32e-09 | 901 | 41 | 14 | int:H3C1 |
| Interaction | H2BC21 interactions | PHF2 NUCKS1 KMT2A DIDO1 QSER1 SRBD1 MAP1B CDC27 CDCA5 CTR9 MAP4K1 RAI1 | 8.25e-09 | 696 | 41 | 12 | int:H2BC21 |
| Interaction | H2BC8 interactions | PHF2 NUCKS1 KMT2A DIDO1 CHD6 QSER1 SRBD1 CTCF CDCA5 RAI1 KNOP1 | 1.37e-08 | 576 | 41 | 11 | int:H2BC8 |
| Interaction | H3C3 interactions | 4.13e-08 | 495 | 41 | 10 | int:H3C3 | |
| Interaction | SMC5 interactions | USP36 PHF2 KMT2A DIDO1 TAF1 QSER1 MAP1B CTCF TAF1L CDCA5 HNRNPAB RAI1 KNOP1 | 4.93e-08 | 1000 | 41 | 13 | int:SMC5 |
| Interaction | ZNF330 interactions | 2.20e-07 | 446 | 41 | 9 | int:ZNF330 | |
| Interaction | POLR1E interactions | 4.43e-07 | 350 | 41 | 8 | int:POLR1E | |
| Interaction | CENPA interactions | 7.76e-07 | 377 | 41 | 8 | int:CENPA | |
| Interaction | SCN10A interactions | 1.28e-06 | 11 | 41 | 3 | int:SCN10A | |
| Interaction | H2BC3 interactions | 1.35e-06 | 406 | 41 | 8 | int:H2BC3 | |
| Interaction | H3-3A interactions | 1.87e-06 | 749 | 41 | 10 | int:H3-3A | |
| Interaction | SCN11A interactions | 3.50e-06 | 15 | 41 | 3 | int:SCN11A | |
| Interaction | CFAP141 interactions | 4.66e-06 | 55 | 41 | 4 | int:CFAP141 | |
| Interaction | MKI67 interactions | 4.85e-06 | 648 | 41 | 9 | int:MKI67 | |
| Interaction | POLR1G interactions | 5.36e-06 | 489 | 41 | 8 | int:POLR1G | |
| Interaction | ANAPC15 interactions | 5.96e-06 | 128 | 41 | 5 | int:ANAPC15 | |
| Interaction | PARP1 interactions | USP36 PHF2 NUCKS1 DIDO1 CHD6 CTNNA1 SRBD1 CTCF CTR9 HNRNPAB RAI1 KNOP1 | 7.66e-06 | 1316 | 41 | 12 | int:PARP1 |
| Interaction | H2AZ1 interactions | 8.88e-06 | 371 | 41 | 7 | int:H2AZ1 | |
| Interaction | LLPH interactions | 8.91e-06 | 139 | 41 | 5 | int:LLPH | |
| Interaction | ASF1A interactions | 1.05e-05 | 249 | 41 | 6 | int:ASF1A | |
| Interaction | TERF2IP interactions | 1.30e-05 | 552 | 41 | 8 | int:TERF2IP | |
| Interaction | CACNA1D interactions | 1.54e-05 | 24 | 41 | 3 | int:CACNA1D | |
| Interaction | HECTD1 interactions | DIDO1 TACC2 TAF1 PPP2R5D MB21D2 SRBD1 MAP1B CDC27 HNRNPAB KNOP1 | 2.07e-05 | 984 | 41 | 10 | int:HECTD1 |
| Interaction | RPL27 interactions | 2.34e-05 | 431 | 41 | 7 | int:RPL27 | |
| Interaction | SCN1A interactions | 2.75e-05 | 29 | 41 | 3 | int:SCN1A | |
| Interaction | MEN1 interactions | KMT2A DIDO1 TAF1 PPP2R5D QSER1 SRBD1 CTCF HNRNPAB KNOP1 WDR46 | 3.04e-05 | 1029 | 41 | 10 | int:MEN1 |
| Interaction | LINC02910 interactions | 4.11e-05 | 95 | 41 | 4 | int:LINC02910 | |
| Interaction | HECW2 interactions | 4.46e-05 | 322 | 41 | 6 | int:HECW2 | |
| Interaction | DDX23 interactions | 4.64e-05 | 480 | 41 | 7 | int:DDX23 | |
| Interaction | GAGE2E interactions | 5.33e-05 | 36 | 41 | 3 | int:GAGE2E | |
| Interaction | FEV interactions | 5.51e-05 | 203 | 41 | 5 | int:FEV | |
| Interaction | BRD3 interactions | 5.56e-05 | 494 | 41 | 7 | int:BRD3 | |
| Interaction | CACNA1B interactions | 5.79e-05 | 37 | 41 | 3 | int:CACNA1B | |
| Interaction | NUCKS1 interactions | 8.06e-05 | 220 | 41 | 5 | int:NUCKS1 | |
| Interaction | XRCC6 interactions | 8.29e-05 | 928 | 41 | 9 | int:XRCC6 | |
| Interaction | RPL32 interactions | 8.52e-05 | 362 | 41 | 6 | int:RPL32 | |
| Interaction | CTR9 interactions | 1.06e-04 | 233 | 41 | 5 | int:CTR9 | |
| Interaction | COIL interactions | 1.12e-04 | 552 | 41 | 7 | int:COIL | |
| Interaction | SCN4B interactions | 1.12e-04 | 8 | 41 | 2 | int:SCN4B | |
| Interaction | CACNA1A interactions | 1.12e-04 | 123 | 41 | 4 | int:CACNA1A | |
| Interaction | SCN5A interactions | 1.19e-04 | 47 | 41 | 3 | int:SCN5A | |
| Interaction | CHD3 interactions | 1.21e-04 | 757 | 41 | 8 | int:CHD3 | |
| Interaction | NAA40 interactions | 1.24e-04 | 978 | 41 | 9 | int:NAA40 | |
| Interaction | H2AJ interactions | 1.27e-04 | 127 | 41 | 4 | int:H2AJ | |
| Interaction | AR interactions | 1.38e-04 | 992 | 41 | 9 | int:AR | |
| Interaction | DHX40 interactions | 1.44e-04 | 249 | 41 | 5 | int:DHX40 | |
| Interaction | TBP interactions | 1.55e-04 | 253 | 41 | 5 | int:TBP | |
| Interaction | PUM3 interactions | 1.58e-04 | 254 | 41 | 5 | int:PUM3 | |
| Interaction | FGFBP1 interactions | 1.67e-04 | 257 | 41 | 5 | int:FGFBP1 | |
| Interaction | RPL13A interactions | 1.70e-04 | 591 | 41 | 7 | int:RPL13A | |
| Interaction | UQCR11 interactions | 1.71e-04 | 53 | 41 | 3 | int:UQCR11 | |
| Interaction | RRP8 interactions | 1.73e-04 | 259 | 41 | 5 | int:RRP8 | |
| Interaction | SGO1 interactions | 1.75e-04 | 138 | 41 | 4 | int:SGO1 | |
| Interaction | ANOS1 interactions | 2.01e-04 | 143 | 41 | 4 | int:ANOS1 | |
| Interaction | BRD2 interactions | 2.15e-04 | 429 | 41 | 6 | int:BRD2 | |
| Interaction | RPL26L1 interactions | 2.20e-04 | 431 | 41 | 6 | int:RPL26L1 | |
| Interaction | NUP43 interactions | 2.40e-04 | 625 | 41 | 7 | int:NUP43 | |
| Interaction | CSNK2B interactions | 2.40e-04 | 625 | 41 | 7 | int:CSNK2B | |
| Interaction | RPL22 interactions | 2.46e-04 | 440 | 41 | 6 | int:RPL22 | |
| Interaction | RCOR2 interactions | 2.47e-04 | 60 | 41 | 3 | int:RCOR2 | |
| Interaction | RPL18A interactions | 2.68e-04 | 447 | 41 | 6 | int:RPL18A | |
| Interaction | H3-4 interactions | 2.71e-04 | 448 | 41 | 6 | int:H3-4 | |
| Interaction | CTCFL interactions | 2.72e-04 | 62 | 41 | 3 | int:CTCFL | |
| Interaction | RBBP5 interactions | 2.79e-04 | 287 | 41 | 5 | int:RBBP5 | |
| Interaction | TAF4 interactions | 2.80e-04 | 156 | 41 | 4 | int:TAF4 | |
| Interaction | WDR5 interactions | 3.01e-04 | 1101 | 41 | 9 | int:WDR5 | |
| Interaction | ANAPC7 interactions | 3.23e-04 | 162 | 41 | 4 | int:ANAPC7 | |
| Interaction | NALCN interactions | 3.62e-04 | 14 | 41 | 2 | int:NALCN | |
| Interaction | NR2C2 interactions | 3.96e-04 | 1403 | 41 | 10 | int:NR2C2 | |
| Interaction | KMT2A interactions | 4.21e-04 | 314 | 41 | 5 | int:KMT2A | |
| Interaction | ADARB1 interactions | 4.33e-04 | 489 | 41 | 6 | int:ADARB1 | |
| Interaction | DDB1 interactions | 4.63e-04 | 697 | 41 | 7 | int:DDB1 | |
| Interaction | H2BC12 interactions | 4.72e-04 | 322 | 41 | 5 | int:H2BC12 | |
| Interaction | LAS1L interactions | 5.02e-04 | 182 | 41 | 4 | int:LAS1L | |
| Interaction | RPL36 interactions | 5.08e-04 | 504 | 41 | 6 | int:RPL36 | |
| Interaction | HP1BP3 interactions | 5.20e-04 | 329 | 41 | 5 | int:HP1BP3 | |
| Interaction | H1-1 interactions | 5.24e-04 | 507 | 41 | 6 | int:H1-1 | |
| Interaction | IFI16 interactions | 5.35e-04 | 714 | 41 | 7 | int:IFI16 | |
| Interaction | KAT6A interactions | 5.40e-04 | 510 | 41 | 6 | int:KAT6A | |
| Interaction | RPS3 interactions | 5.67e-04 | 721 | 41 | 7 | int:RPS3 | |
| Interaction | NUP50 interactions | 6.12e-04 | 341 | 41 | 5 | int:NUP50 | |
| Interaction | FBXW7 interactions | 6.19e-04 | 1215 | 41 | 9 | int:FBXW7 | |
| Interaction | CHD8 interactions | 6.26e-04 | 193 | 41 | 4 | int:CHD8 | |
| Interaction | RRS1 interactions | 6.45e-04 | 345 | 41 | 5 | int:RRS1 | |
| Interaction | SIRT7 interactions | 6.83e-04 | 744 | 41 | 7 | int:SIRT7 | |
| Interaction | TAF5 interactions | 7.11e-04 | 86 | 41 | 3 | int:TAF5 | |
| Interaction | CEBPA interactions | 7.38e-04 | 1245 | 41 | 9 | int:CEBPA | |
| Interaction | SCN9A interactions | 8.27e-04 | 21 | 41 | 2 | int:SCN9A | |
| Interaction | TAF1L interactions | 9.09e-04 | 22 | 41 | 2 | int:TAF1L | |
| Interaction | MECP2 interactions | 9.36e-04 | 1287 | 41 | 9 | int:MECP2 | |
| Interaction | KRR1 interactions | 9.84e-04 | 379 | 41 | 5 | int:KRR1 | |
| Interaction | RBBP4 interactions | 9.92e-04 | 573 | 41 | 6 | int:RBBP4 | |
| Interaction | RUVBL1 interactions | 1.01e-03 | 575 | 41 | 6 | int:RUVBL1 | |
| Interaction | NCL interactions | 1.03e-03 | 798 | 41 | 7 | int:NCL | |
| Interaction | ZNF510 interactions | 1.08e-03 | 24 | 41 | 2 | int:ZNF510 | |
| Interaction | RPL37A interactions | 1.13e-03 | 391 | 41 | 5 | int:RPL37A | |
| Interaction | KLF3 interactions | 1.16e-03 | 228 | 41 | 4 | int:KLF3 | |
| Interaction | IQCF2 interactions | 1.18e-03 | 25 | 41 | 2 | int:IQCF2 | |
| Interaction | GAR1 interactions | 1.24e-03 | 232 | 41 | 4 | int:GAR1 | |
| Interaction | FBP2 interactions | 1.27e-03 | 26 | 41 | 2 | int:FBP2 | |
| Cytoband | 2q24.3 | 3.95e-07 | 16 | 42 | 3 | 2q24.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 5.76e-06 | 127 | 42 | 4 | chr2q24 | |
| Cytoband | 3p22.2 | 2.23e-04 | 24 | 42 | 2 | 3p22.2 | |
| Cytoband | 1q32.1 | 4.44e-03 | 108 | 42 | 2 | 1q32.1 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 9.26e-13 | 9 | 29 | 5 | 1203 | |
| GeneFamily | PHD finger proteins | 3.97e-04 | 90 | 29 | 3 | 88 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.14e-03 | 161 | 29 | 3 | 593 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 5.00e-03 | 66 | 29 | 2 | 722 | |
| Coexpression | ZHENG_CORD_BLOOD_C10_MULTILYMPHOID_PROGENITOR | 4.77e-07 | 97 | 42 | 5 | M39219 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDC_UP | 1.66e-05 | 200 | 42 | 5 | M3830 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_500 | 2.26e-06 | 206 | 40 | 6 | gudmap_developingKidney_e15.5_Peripheral blastema_500_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000 | 1.68e-05 | 819 | 40 | 9 | gudmap_developingKidney_e15.5_Peripheral blastema_1000 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.17e-06 | 198 | 42 | 5 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.17e-06 | 198 | 42 | 5 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.17e-06 | 198 | 42 | 5 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.37e-05 | 155 | 42 | 4 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D175|Adult / Lineage, Cell type, age group and donor | 1.88e-05 | 168 | 42 | 4 | 14071b961c9bdb54a8259b12a88237b802cbde36 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-05 | 188 | 42 | 4 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-05 | 188 | 42 | 4 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-05 | 189 | 42 | 4 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.04e-05 | 190 | 42 | 4 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-05 | 193 | 42 | 4 | 5fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.37e-05 | 195 | 42 | 4 | 787e95fb59c40bba784544b662fac37606ae1427 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.43e-05 | 196 | 42 | 4 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.43e-05 | 196 | 42 | 4 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.57e-05 | 198 | 42 | 4 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.57e-05 | 198 | 42 | 4 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Striatum-Neuronal|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.72e-05 | 200 | 42 | 4 | c888fd487990cad482a4ca47601cdebc0ca3f3ce | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 3.72e-05 | 200 | 42 | 4 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Intermediate|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.97e-04 | 120 | 42 | 3 | eb5b88c47dd4a6f9b55ace24f19d4e81d4ed31e1 | |
| ToppCell | remission-unassigned|remission / disease stage, cell group and cell class | 4.09e-04 | 154 | 42 | 3 | 4130769829b838cc8a075c87ff6c187f0f507f8b | |
| ToppCell | remission-unassigned|World / disease stage, cell group and cell class | 4.17e-04 | 155 | 42 | 3 | d81bec894381e3e2d6249a567e8108b8423e5c54 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 4.58e-04 | 160 | 42 | 3 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.66e-04 | 161 | 42 | 3 | 0dd1401b4c990d49fccb702a9f9867590a58e203 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1-Mitotic.MkI67_(Mitotic.MkI67)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.66e-04 | 161 | 42 | 3 | b6a31c033edc74f23a20aab1f18e80cc83ffee4c | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 4.66e-04 | 161 | 42 | 3 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | Bac-SEP-Lymphocyte-B-B_intermediate|Bac-SEP / Disease, Lineage and Cell Type | 4.66e-04 | 161 | 42 | 3 | bcd122af09cbb99d1816200d9c367af8b7f36873 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.66e-04 | 161 | 42 | 3 | 133b4fadb499e842c19f573f9cf09ce08c1d4813 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.66e-04 | 161 | 42 | 3 | cb177ca10d848d0e25399ab5ebfcde1071fb94c2 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.66e-04 | 161 | 42 | 3 | efb811dda4d73107983a5f68302bdcf4f408d5b4 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.66e-04 | 161 | 42 | 3 | 9466b8658244116f8d21f2f88fb8c2d184b1bdf2 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1-Mitotic.MkI67_(Mitotic.MkI67)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.66e-04 | 161 | 42 | 3 | 28d5dbd20c9f8e0069f172d552997a044790e1a7 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-Plasma_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.75e-04 | 162 | 42 | 3 | 8278dccdb139396ede34b83b02ebce837f2489d6 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.75e-04 | 162 | 42 | 3 | 96c6e94a10b124a1d25dcd705ec5aaa8609c1089 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-04 | 163 | 42 | 3 | 5efecdd8a069a822bc9d35b407092925a865e629 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-04 | 163 | 42 | 3 | 0d94a427f86e62aba12c397c6d7b8cd297f3a0e5 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.92e-04 | 164 | 42 | 3 | b0ed8cb6000ce8bf94444307e4b7b3574fa3fab2 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.92e-04 | 164 | 42 | 3 | 249d8f75a64bce7db52ce0c563f496b9edf602a6 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.92e-04 | 164 | 42 | 3 | 6fb2136168f430babfeb81ca7e151ca7a8092ec4 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.92e-04 | 164 | 42 | 3 | 3aea6207a011ad55a1aeb2ed9fb54d31b23694b5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.01e-04 | 165 | 42 | 3 | 9bd332e5ede759a00a47728ea5558c215efdd77a | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 5.01e-04 | 165 | 42 | 3 | 9795ce31689bc63f5a2d68725ef00b23a90c3846 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.27e-04 | 168 | 42 | 3 | e20e1936573fdde78426d7a4eb45c458d5c4dbb4 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 5.27e-04 | 168 | 42 | 3 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.27e-04 | 168 | 42 | 3 | 16b517e3159ad6e6d25fd48f7d5f46e77b2b318d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.37e-04 | 169 | 42 | 3 | 0332f539a2f7d6dcd081a5d2f567290721f5a329 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-B_cells-Cycling_B_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.37e-04 | 169 | 42 | 3 | a34aff9257ae9746226ee7af595c4678a4b0c896 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.65e-04 | 172 | 42 | 3 | ca0cc0e92b6cdce5016f18fcb2ec1508cb222502 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.65e-04 | 172 | 42 | 3 | 76c06a968d3333441eed103abef1e636a1c3e7a1 | |
| ToppCell | 3'_v3-blood-Lymphocytic_B-Naive_B_cells|blood / Manually curated celltypes from each tissue | 5.65e-04 | 172 | 42 | 3 | f16f90d17feac1ee52fd513907b28456865fd31d | |
| ToppCell | Endothelial-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 5.65e-04 | 172 | 42 | 3 | d4e98ff9c7cbc95457e1d71fa60f151a2f178dae | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-regulatory_T_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.65e-04 | 172 | 42 | 3 | 425970e9ce8943f7e2ba6ca958e7a3a29baa798c | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.74e-04 | 173 | 42 | 3 | 7e3897868dd3f6e4974f593c60649a543ffc8693 | |
| ToppCell | BL-critical-LOC-Lymphoid-PC|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.74e-04 | 173 | 42 | 3 | 90700a876d997f7c0f7b3899dffcda7fdafee547 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.84e-04 | 174 | 42 | 3 | a62531ebf16b32b249168dca11b870f63a8aa81c | |
| ToppCell | COVID-19-Heart-VSMC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.94e-04 | 175 | 42 | 3 | 1125f0d3a5b2388fa77a820dea0288e824d84a82 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.94e-04 | 175 | 42 | 3 | 787ac1a12cda10af5c8830471702a4cbaf43e79e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.04e-04 | 176 | 42 | 3 | b942227abf9902ba13fac6c3e9efb0cacc82af94 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-04 | 177 | 42 | 3 | 1dc69c661e70e7e22bd9d7cf953eb638da9fd43c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-04 | 177 | 42 | 3 | dc846d0feb94d4c289553cc3ac9dac81d10409cb | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-04 | 177 | 42 | 3 | 426a9845df7fd13b02e744532c336c60bc4d4a22 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-04 | 177 | 42 | 3 | dbdbdc8ed9ef0b529694242ef9f9f07a42e16005 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-04 | 179 | 42 | 3 | 8da6863edc756540bb097cc7221c1408640d9bb4 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.34e-04 | 179 | 42 | 3 | 8ce5000088b727783a0619baa16a2cd036d21f54 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.34e-04 | 179 | 42 | 3 | 666072c0e8448dbaec1683d18368ec2502453f90 | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.34e-04 | 179 | 42 | 3 | af0b54c9ea0b6e4210f22dbb6e88ecd3276a5f86 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-04 | 179 | 42 | 3 | f39c13c99a07d009cc677e363ffe089089c64916 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.45e-04 | 180 | 42 | 3 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.45e-04 | 180 | 42 | 3 | 788d5fbf688365b5d92d3aa19b9f8e9448f8be5a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-04 | 180 | 42 | 3 | f6a2208960d0df1500c974cc44c3c054cd7475a9 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-04 | 181 | 42 | 3 | 429df38438d5a7ff490c9ede34b69e2970c7ded2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.55e-04 | 181 | 42 | 3 | 6873c1138b28c130637d06b64981ad11c262e85f | |
| ToppCell | RA-07._Pericyte|RA / Chamber and Cluster_Paper | 6.55e-04 | 181 | 42 | 3 | 8dfb42d096db6c2df9b41303a7199d134d4bff07 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-04 | 181 | 42 | 3 | 395cf5aa2d89b05328ab516b8c89401020b6d830 | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 6.66e-04 | 182 | 42 | 3 | 812dac35b9aa05be48258082e007f6c00e7b4dd8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.66e-04 | 182 | 42 | 3 | 5f513bbb7125956eb528e3120de3fd776770a7c3 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 6.66e-04 | 182 | 42 | 3 | 04ccfa951eaa31fed6d140edb6c702d49363c5fa | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.66e-04 | 182 | 42 | 3 | 398ce074a04f6482470b488f1affae4af7d2ec58 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.76e-04 | 183 | 42 | 3 | b5ede5a0048c585b73c00e88aeddbcaf669347b1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.76e-04 | 183 | 42 | 3 | d340ab5a77e8d819a1dfb4ca3e9a4b9bc988923c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.76e-04 | 183 | 42 | 3 | ba7753e9fe2a6a87c5264f299ac97da2ddbda178 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 6.76e-04 | 183 | 42 | 3 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | LV-07._Pericyte|World / Chamber and Cluster_Paper | 6.76e-04 | 183 | 42 | 3 | 273db6a3b00a93ca852498471187b642b5368185 | |
| ToppCell | LA-07._Pericyte|World / Chamber and Cluster_Paper | 6.76e-04 | 183 | 42 | 3 | e3835db4795362b0442d5893baf2a78efcc20428 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.76e-04 | 183 | 42 | 3 | 8d45dff06a199b1369576657f7f9dc0249c5f841 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.76e-04 | 183 | 42 | 3 | 421265fa15d5a028cb567bb0904e670473ef102b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.76e-04 | 183 | 42 | 3 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 6.76e-04 | 183 | 42 | 3 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.87e-04 | 184 | 42 | 3 | 0ba243cbf69b4fe6ae100a7f0314317bec38026c | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-04 | 184 | 42 | 3 | 3da93e7d8b62463e307cc0425c47dbd3bef66799 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.87e-04 | 184 | 42 | 3 | 9690d4290e70f9bda889754ffb30b0af1f7cb94b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-04 | 184 | 42 | 3 | 7d9bcdaff8cbea4c50ab7db0f8e01f6bbd0ef593 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.87e-04 | 184 | 42 | 3 | 2a8338e94937686a148b5433515700ca0f674058 | |
| ToppCell | LA-07._Pericyte|LA / Chamber and Cluster_Paper | 6.98e-04 | 185 | 42 | 3 | ba5baa4d7f097108622674de5b7f4fd279843d24 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.98e-04 | 185 | 42 | 3 | 3d73b3e0bceb192257e5cfbe64b7ccb379b6e22d | |
| ToppCell | 18-Distal-Epithelial-Neuroendocrine|Distal / Age, Tissue, Lineage and Cell class | 6.98e-04 | 185 | 42 | 3 | f8fc7b12b4e18d23d84e95488be93c4352d325f3 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-04 | 185 | 42 | 3 | 70de48988c1f8e0809afc8092b663aa439d8e528 | |
| ToppCell | LV-07._Pericyte|LV / Chamber and Cluster_Paper | 6.98e-04 | 185 | 42 | 3 | acb38eba871ec72f2a8136a33b87d33b8c85465d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.09e-04 | 186 | 42 | 3 | d65fa6d8e8a195ea10cfde1499d096d6acf7a634 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-04 | 186 | 42 | 3 | d1d01ce46e62944aa9864eda47e8401b5f0d2bdc | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.09e-04 | 186 | 42 | 3 | 08632045d499e61dd96ff29a5a9a208afe58dc58 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.09e-04 | 186 | 42 | 3 | b3358e0fa6d845c81e94d56c8575f016621d28ff | |
| Drug | Zonisamide | 2.12e-08 | 17 | 41 | 4 | DB00909 | |
| Drug | APETx1, Anthopleura elegantissima | 1.08e-07 | 6 | 41 | 3 | ctd:C475726 | |
| Drug | fenpropathrin | 1.08e-07 | 6 | 41 | 3 | ctd:C044267 | |
| Drug | 2,3,5,6-tetrafluoro-4-methylbenzyl (Z)-(1RS)-cis-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate | 3.02e-07 | 8 | 41 | 3 | ctd:C489827 | |
| Drug | Mfpa | 9.48e-06 | 3 | 41 | 2 | CID003035615 | |
| Drug | Sodium | 1.57e-05 | 84 | 41 | 4 | ctd:D012964 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.60e-05 | 177 | 41 | 5 | 3227_DN | |
| Drug | trichostatin A; Down 200; 0.1uM; MCF7; HG-U133A | 1.69e-05 | 179 | 41 | 5 | 331_DN | |
| Drug | APETx2 protein, Anthopleura elegantissima | 1.89e-05 | 4 | 41 | 2 | ctd:C501880 | |
| Drug | cyfluthrin | 1.92e-05 | 29 | 41 | 3 | ctd:C052570 | |
| Drug | Dinoprost trometamol [38362-01-5]; Down 200; 8.4uM; HL60; HT_HG-U133A | 2.55e-05 | 195 | 41 | 5 | 2446_DN | |
| Drug | Melatonin [73-31-4]; Down 200; 17.2uM; HL60; HT_HG-U133A | 2.62e-05 | 196 | 41 | 5 | 2431_DN | |
| Drug | Topiramate | 3.15e-05 | 5 | 41 | 2 | DB00273 | |
| Drug | benzocaine | 4.04e-05 | 37 | 41 | 3 | CID000002337 | |
| Drug | lamotrigine | 5.60e-05 | 116 | 41 | 4 | CID000003878 | |
| Drug | Cocaine | 8.80e-05 | 8 | 41 | 2 | DB00907 | |
| Drug | decamethrin | 1.37e-04 | 146 | 41 | 4 | ctd:C017180 | |
| Drug | Nitrazepam | 1.72e-04 | 11 | 41 | 2 | DB01595 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.09e-04 | 163 | 41 | 4 | 7453_DN | |
| Drug | saxitoxin | 2.19e-04 | 65 | 41 | 3 | CID000037165 | |
| Drug | 2-phenylindole | 2.44e-04 | 13 | 41 | 2 | CID000013698 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.45e-04 | 170 | 41 | 4 | 1050_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.50e-04 | 171 | 41 | 4 | 5441_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.56e-04 | 172 | 41 | 4 | 1072_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.56e-04 | 172 | 41 | 4 | 5903_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.62e-04 | 173 | 41 | 4 | 2881_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.68e-04 | 174 | 41 | 4 | 3993_DN | |
| Drug | 1,2-Dsmgg | 2.84e-04 | 14 | 41 | 2 | CID000193820 | |
| Drug | T2755 | 2.85e-04 | 71 | 41 | 3 | CID000005514 | |
| Drug | flecainide | 2.85e-04 | 71 | 41 | 3 | CID000003355 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.92e-04 | 178 | 41 | 4 | 992_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.92e-04 | 178 | 41 | 4 | 1112_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 3.04e-04 | 180 | 41 | 4 | 4541_DN | |
| Drug | geldanamycin; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 3.18e-04 | 182 | 41 | 4 | 1008_UP | |
| Drug | apholate | 3.27e-04 | 15 | 41 | 2 | CID000005845 | |
| Drug | Ampyrone [83-07-8]; Down 200; 19.6uM; PC3; HT_HG-U133A | 3.74e-04 | 190 | 41 | 4 | 4507_DN | |
| Drug | Chloroquine diphosphate [50-63-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 3.74e-04 | 190 | 41 | 4 | 2869_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; MCF7; HT_HG-U133A_EA | 3.81e-04 | 191 | 41 | 4 | 994_UP | |
| Drug | Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 3.89e-04 | 192 | 41 | 4 | 4104_DN | |
| Drug | Forskolin, from Coleus forskohlii; Down 200; 0.5uM; PC3; HT_HG-U133A | 3.97e-04 | 193 | 41 | 4 | 7059_DN | |
| Drug | 5211181; Up 200; 12uM; MCF7; HT_HG-U133A_EA | 3.97e-04 | 193 | 41 | 4 | 950_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; HL60; HT_HG-U133A | 4.04e-04 | 194 | 41 | 4 | 6173_UP | |
| Drug | Stachydrine hydrochloride; Down 200; 22.2uM; MCF7; HT_HG-U133A | 4.04e-04 | 194 | 41 | 4 | 2743_DN | |
| Drug | (-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 4.04e-04 | 194 | 41 | 4 | 3539_DN | |
| Drug | Rolipram [61413-54-5]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 4.12e-04 | 195 | 41 | 4 | 5330_UP | |
| Drug | Oxymetazoline hydrochloride [2315-02-8]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 4.12e-04 | 195 | 41 | 4 | 2278_DN | |
| Drug | Biperiden hydrochloride [1235-82-1]; Down 200; 11.4uM; HL60; HT_HG-U133A | 4.12e-04 | 195 | 41 | 4 | 2460_DN | |
| Drug | Procarbazine hydrochloride [366-70-1]; Down 200; 15.6uM; HL60; HT_HG-U133A | 4.12e-04 | 195 | 41 | 4 | 2971_DN | |
| Drug | Phenethicillin potassium salt [132-93-4]; Down 200; 10uM; PC3; HT_HG-U133A | 4.12e-04 | 195 | 41 | 4 | 5763_DN | |
| Drug | Tolazoline hydrochloride [59-97-2]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 4.20e-04 | 196 | 41 | 4 | 4844_DN | |
| Drug | Mesoridazine besylate [32672-69-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 4.20e-04 | 196 | 41 | 4 | 7017_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A | 4.20e-04 | 196 | 41 | 4 | 2681_UP | |
| Drug | PD 150606 | 4.23e-04 | 17 | 41 | 2 | ctd:C100442 | |
| Drug | clf2 | 4.23e-04 | 17 | 41 | 2 | CID000141144 | |
| Drug | Vigabatrin [60643-86-9]; Down 200; 31uM; HL60; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 2452_DN | |
| Drug | Hexetidine [141-94-6]; Down 200; 11.8uM; HL60; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 2457_DN | |
| Drug | Vancomycin hydrochloride [1404-93-9]; Up 200; 2.6uM; MCF7; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 2858_UP | |
| Drug | Retrorsine [480-54-6]; Up 200; 11.4uM; HL60; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 2129_UP | |
| Drug | Hexylcaine hydrochloride [532-76-3]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 3447_UP | |
| Drug | Clofazimine [2030-63-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 3239_DN | |
| Drug | Paromomycin sulfate [1263-89-4]; Up 200; 5.6uM; HL60; HT_HG-U133A | 4.37e-04 | 198 | 41 | 4 | 3017_UP | |
| Drug | nocodazole; Down 200; 1uM; MCF7; HG-U133A | 4.37e-04 | 198 | 41 | 4 | 621_DN | |
| Drug | 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A | 4.37e-04 | 198 | 41 | 4 | 7557_DN | |
| Drug | Ethoxyquin [91-53-2]; Up 200; 18.4uM; HL60; HT_HG-U133A | 4.37e-04 | 198 | 41 | 4 | 2559_UP | |
| Drug | Glimepiride [93479-97-1]; Up 200; 8.2uM; HL60; HT_HG-U133A | 4.37e-04 | 198 | 41 | 4 | 2154_UP | |
| Drug | Myricetin [529-44-2]; Down 200; 12.6uM; PC3; HT_HG-U133A | 4.37e-04 | 198 | 41 | 4 | 4090_DN | |
| Drug | Ceforanide [60925-61-3]; Down 200; 7.6uM; HL60; HT_HG-U133A | 4.37e-04 | 198 | 41 | 4 | 2447_DN | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HG-U133A | 4.37e-04 | 198 | 41 | 4 | 426_DN | |
| Drug | Mevalonic-D, L acid lactone [674-26-0]; Down 200; 30.8uM; PC3; HT_HG-U133A | 4.37e-04 | 198 | 41 | 4 | 5738_DN | |
| Drug | Trimethoprim [738-70-5]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 4.37e-04 | 198 | 41 | 4 | 4701_UP | |
| Drug | Oxybenzone [131-57-7]; Down 200; 17.6uM; HL60; HT_HG-U133A | 4.37e-04 | 198 | 41 | 4 | 3092_DN | |
| Drug | (-)-MK 801 hydrogen maleate [77086-19-2]; Up 200; 11.8uM; PC3; HT_HG-U133A | 4.37e-04 | 198 | 41 | 4 | 6657_UP | |
| Drug | Hydroxyzine dihydrochloride [2192-20-3]; Down 200; 9uM; HL60; HG-U133A | 4.45e-04 | 199 | 41 | 4 | 2024_DN | |
| Drug | Propylthiouracil [51-52-5]; Up 200; 23.4uM; HL60; HT_HG-U133A | 4.45e-04 | 199 | 41 | 4 | 2476_UP | |
| Drug | Scorpion Venoms | 4.75e-04 | 18 | 41 | 2 | ctd:D012604 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.14e-12 | 10 | 42 | 5 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.14e-12 | 10 | 42 | 5 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 3.59e-12 | 12 | 42 | 5 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 2.16e-07 | 93 | 42 | 5 | C1535926 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 7.59e-07 | 13 | 42 | 3 | C0751122 | |
| Disease | Intellectual Disability | 2.98e-06 | 447 | 42 | 7 | C3714756 | |
| Disease | epilepsy (implicated_via_orthology) | 3.49e-06 | 163 | 42 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | anxiety disorder (implicated_via_orthology) | 4.05e-06 | 22 | 42 | 3 | DOID:2030 (implicated_via_orthology) | |
| Disease | PAROXYSMAL EXTREME PAIN DISORDER | 5.93e-06 | 3 | 42 | 2 | C1833661 | |
| Disease | Primary Erythermalgia | 5.93e-06 | 3 | 42 | 2 | C0014805 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 4.13e-05 | 7 | 42 | 2 | C0020075 | |
| Disease | Seizure, Febrile, Simple | 4.13e-05 | 7 | 42 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 4.13e-05 | 7 | 42 | 2 | C0751057 | |
| Disease | Congenital Pain Insensitivity | 4.13e-05 | 7 | 42 | 2 | C0002768 | |
| Disease | Febrile Convulsions | 7.08e-05 | 9 | 42 | 2 | C0009952 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 7.08e-05 | 9 | 42 | 2 | C3502809 | |
| Disease | sleep time | 8.84e-05 | 10 | 42 | 2 | EFO_0005274 | |
| Disease | transient cerebral ischemia (implicated_via_orthology) | 1.05e-04 | 64 | 42 | 3 | DOID:224 (implicated_via_orthology) | |
| Disease | congenital heart disease (implicated_via_orthology) | 1.32e-04 | 69 | 42 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | interleukin 18 measurement | 1.75e-04 | 76 | 42 | 3 | EFO_0004581 | |
| Disease | MMR-related febrile seizures | 2.05e-04 | 15 | 42 | 2 | EFO_0006519 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 2.34e-04 | 16 | 42 | 2 | C0393706 | |
| Disease | uridine diphosphate galactose measurement, uridine diphosphate glucose measurement | 2.65e-04 | 17 | 42 | 2 | EFO_0010543, EFO_0010544 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 2.98e-04 | 18 | 42 | 2 | HP_0002373 | |
| Disease | social communication impairment | 9.55e-04 | 32 | 42 | 2 | EFO_0005427 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.33e-03 | 152 | 42 | 3 | DOID:0060041 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PPEKQKRKKKKMPEI | 211 | Q96FF9 | |
| VGNMKPPKPTKIKKK | 246 | P49711 | |
| MPYKLKKEKEPPKVA | 1 | Q14738 | |
| SPKTMKKLLPKRKPE | 676 | Q14155 | |
| MGKKIKKEVEPPPKD | 1 | Q5W041 | |
| PKPMPKNKRKLRKME | 276 | Q8NBA8 | |
| VILKPKMLDKKKPTP | 126 | Q53SF7 | |
| KMLDKKKPTPIIPEK | 131 | Q53SF7 | |
| CLPKKKPKLKEKVRP | 1711 | Q7Z5J4 | |
| KVKQPKVKAEPPPKK | 1486 | Q2KHR3 | |
| MVKKSKPERKEKKMP | 156 | Q9H1E3 | |
| KPERKEKKMPKPRLK | 161 | Q9H1E3 | |
| KLVPKHKKKIQPRKM | 126 | Q8IZA3 | |
| KPPKVESKEKVMVKK | 576 | P46821 | |
| KKPQRGMPKVEKVEK | 201 | Q8IYB1 | |
| GQAPEMPLVKKKKKK | 56 | Q1ED39 | |
| PEKPKKVKDPLIKKN | 351 | P14867 | |
| MAPKKPEPKKEAAKP | 1 | P12829 | |
| FKKMLKKRAPPAPKK | 166 | Q8N9C0 | |
| MKAPEKKPLVKREKQ | 861 | P35221 | |
| EPKEPRKAKEPKKAK | 126 | Q8TD26 | |
| KKKAPKPERLPPSMK | 991 | Q6PD62 | |
| EKMKMKPEKPSLPKC | 441 | Q9BTC0 | |
| KQKPKEKEKPPPVNK | 1356 | Q03164 | |
| KKRAPPAPKKKMDLE | 151 | Q86VF2 | |
| LKMKFPPKIPNRKTK | 396 | P30260 | |
| LDKPPLLPPKKEKMK | 466 | Q92918 | |
| PKKAMAMKKDPVKKI | 141 | Q99729 | |
| KKTPKTVKMPKPSKI | 491 | O75151 | |
| PEKKPKKMKERPDLK | 1266 | Q8IZX4 | |
| PPEKKPKKMKERPDL | 1246 | P21675 | |
| KKRPPPVEKKKILGM | 541 | A6NM43 | |
| MKKLGSKKPQKPIPR | 1496 | Q9NY46 | |
| TNKKVKPKIPKMKDR | 41 | Q15198 | |
| PKESKPKRMPRVKKN | 56 | Q8N5C6 | |
| MKKLGSKKPQKPIPR | 1511 | P35498 | |
| MKKLGSKKPQKPIPR | 1446 | Q9Y5Y9 | |
| KKMKPAIAPKPKVLK | 46 | Q6ZV73 | |
| MKKLGSKKPQKPIPR | 1501 | Q99250 | |
| MPRNKCKKAGPKPKK | 111 | O15318 | |
| KKPVAKMPLRRPKMK | 2291 | O95359 | |
| KMPLRRPKMKKTPEK | 2296 | O95359 | |
| VPPKKDKLQTKRKKP | 11 | O15213 | |
| MKKLGSKKPQKPIPR | 1336 | Q9UI33 | |
| PEAMEESPRKKKKKK | 946 | Q9P275 |